- Home
- Publications
- Publication Search
- Publication Details
Title
Novelty in Inflammation and Immunomodulation in Migraine
Authors
Keywords
-
Journal
CURRENT PHARMACEUTICAL DESIGN
Volume 25, Issue 27, Pages 2919-2936
Publisher
Bentham Science Publishers Ltd.
Online
2019-10-10
DOI
10.2174/1381612825666190709204107
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications
- (2019) David W Dodick CEPHALALGIA
- European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
- (2019) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- Imaging of neuroinflammation in migraine with aura
- (2019) Daniel S. Albrecht et al. NEUROLOGY
- A new era for migraine: Pharmacokinetic and pharmacodynamic insights into monoclonal antibodies with a focus on galcanezumab, an anti-CGRP antibody
- (2019) William Kielbasa et al. CEPHALALGIA
- Migraine treatment: the doors for the future are open, but with caution and prudence
- (2019) Abouch V. Krymchantowski et al. ARQUIVOS DE NEURO-PSIQUIATRIA
- Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study
- (2019) Peter J Goadsby et al. CEPHALALGIA
- Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets
- (2019) Kristian Agmund Haanes et al. CNS DRUGS
- Fremanezumab as a preventive treatment for episodic and chronic migraine
- (2019) Marcelo E. Bigal et al. Expert Review of Neurotherapeutics
- CGRP and the Trigeminal System in Migraine
- (2019) Smriti Iyengar et al. HEADACHE
- Erenumab in chronic migraine
- (2019) Richard B. Lipton et al. NEUROLOGY
- Anti-CGRP and anti-CGRP receptor monoclonal antibodies as antimigraine agents. Potential differences in safety profile postulated on a pathophysiological basis
- (2019) Giuseppe Tringali et al. PEPTIDES
- Activation of pial and dural macrophages and dendritic cells by cortical spreading depression
- (2018) Aaron J. Schain et al. ANNALS OF NEUROLOGY
- Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial
- (2018) Vladimir Skljarevski et al. CEPHALALGIA
- A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects
- (2018) Orit Cohen-Barak et al. CEPHALALGIA
- Cortical spreading depression as a site of origin for migraine: Role of CGRP
- (2018) Liesl N Close et al. CEPHALALGIA
- ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
- (2018) David W Dodick et al. CEPHALALGIA
- Emerging Treatments in Episodic Migraine
- (2018) Kate W. Grimsrud et al. Current Pain and Headache Reports
- Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine
- (2018) David W. Dodick et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Migraine
- (2018) David W Dodick LANCET
- The pathophysiology of migraine: implications for clinical management
- (2018) Andrew Charles LANCET NEUROLOGY
- Neurogenic inflammation and its role in migraine
- (2018) Roshni Ramachandran Seminars in Immunopathology
- New preventive treatments for migraine
- (2018) Rebecca Burch et al. BMJ-British Medical Journal
- Engineering of Botulinum Neurotoxins for Biomedical Applications
- (2018) Robert Webb Toxins
- New preventive treatments for migraine
- (2018) Rebecca Burch et al. BMJ-British Medical Journal
- Evaluation of Galcanezumab for the Prevention of Episodic Migraine
- (2018) Virginia L. Stauffer et al. JAMA Neurology
- Migraine in Systemic Autoimmune Diseases
- (2018) Cinzia Cavestro et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- PACAP38 and PAC1 receptor blockade: a new target for headache?
- (2018) Eloisa Rubio-Beltrán et al. JOURNAL OF HEADACHE AND PAIN
- The efficacy and safety of calcitonin gene-related peptide monoclonal antibody for episodic migraine: a meta-analysis
- (2018) Yuhan Zhu et al. NEUROLOGICAL SCIENCES
- Galcanezumab in chronic migraine
- (2018) Holland C. Detke et al. NEUROLOGY
- CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study
- (2017) Clara Domínguez et al. HEADACHE
- The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine
- (2017) Lars Edvinsson HEADACHE
- Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody
- (2017) Agustin Melo-Carrillo et al. JOURNAL OF NEUROSCIENCE
- Cortical Spreading Depression Closes Paravascular Space and Impairs Glymphatic Flow: Implications for Migraine Headache
- (2017) Aaron J. Schain et al. JOURNAL OF NEUROSCIENCE
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- Involvement of substance P in the antinociceptive effect of botulinum toxin type A: Evidence from knockout mice
- (2017) Ivica Matak et al. NEUROSCIENCE
- Mast cells in neuroinflammation and brain disorders
- (2017) Erik Hendriksen et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Fremanezumab for the Preventive Treatment of Chronic Migraine
- (2017) Stephen D. Silberstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Controlled Trial of Erenumab for Episodic Migraine
- (2017) Peter J. Goadsby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology
- (2017) Marco Pirazzini et al. PHARMACOLOGICAL REVIEWS
- Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors’ responses to stimulation of TRPV1 and TRPA1 channels: Are we getting closer to solving this puzzle?
- (2016) XiChun Zhang et al. CEPHALALGIA
- Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2016) Hong Sun et al. LANCET NEUROLOGY
- Evidence for brain glial activation in chronic pain patients
- (2015) Marco L. Loggia et al. BRAIN
- Modulation of inflammatory mediators in the trigeminal ganglion by botulinum neurotoxin type A: an organ culture study
- (2015) Jacob Edvinsson et al. JOURNAL OF HEADACHE AND PAIN
- Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
- (2015) Marcelo E Bigal et al. LANCET NEUROLOGY
- The Glymphatic System: A Beginner’s Guide
- (2015) Nadia Aalling Jessen et al. NEUROCHEMICAL RESEARCH
- Change in brain network connectivity during PACAP38-induced migraine attacks
- (2015) Faisal Mohammad Amin et al. NEUROLOGY
- Migraine and neuropeptides
- (2015) János Tajti et al. NEUROPEPTIDES
- OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine
- (2015) Eva Cernuda-Morollón et al. PAIN
- Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38
- (2014) Faisal Mohammad Amin et al. BRAIN
- Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: Therapeutic implications for migraine and other pains
- (2014) Rami Burstein et al. CEPHALALGIA
- PACAP-38 infusion causes sustained vasodilation of the middle meningeal artery in the rat: Possible involvement of mast cells
- (2014) Deepak K Bhatt et al. CEPHALALGIA
- Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP
- (2014) Marcelo E Bigal et al. CEPHALALGIA
- Innervation of Rat and Human Dura Mater and Pericranial Tissues in the Parieto-Temporal Region by Meningeal Afferents
- (2014) Markus Schueler et al. HEADACHE
- Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
- (2014) David W Dodick et al. LANCET NEUROLOGY
- Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
- (2014) David W Dodick et al. LANCET NEUROLOGY
- Pearls and pitfalls in experimental in vivo models of migraine: Dural trigeminovascular nociception
- (2013) Simon Akerman et al. CEPHALALGIA
- Differentiation of Nerve Fibers Storing CGRP and CGRP Receptors in the Peripheral Trigeminovascular System
- (2013) Sajedeh Eftekhari et al. JOURNAL OF PAIN
- Migraine pathophysiology: Anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain
- (2013) Rodrigo Noseda et al. PAIN
- Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR Review 1
- (2012) Anthony J Harmar et al. BRITISH JOURNAL OF PHARMACOLOGY
- Dural mast cell degranulation is a putative mechanism for headache induced by PACAP-38
- (2012) Michael Baun et al. CEPHALALGIA
- Altered functional magnetic resonance imaging resting-state connectivity in periaqueductal gray networks in migraine
- (2011) Caterina Mainero et al. ANNALS OF NEUROLOGY
- Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers
- (2011) Faisal Mohammad Amin et al. CEPHALALGIA
- OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56-Week PREEMPT Clinical Program
- (2011) Sheena K. Aurora et al. HEADACHE
- Method of Injection of OnabotulinumtoxinA for Chronic Migraine: A Safe, Well-Tolerated, and Effective Treatment Paradigm Based on the PREEMPT Clinical Program
- (2010) Andrew Blumenfeld et al. HEADACHE
- Properties of a general PK/PD model of antibody-ligand interactions for therapeutic antibodies that bind to soluble endogenous targets
- (2010) Jasmine P. Davda et al. mAbs
- CGRP and its receptors provide new insights into migraine pathophysiology
- (2010) Tony W. Ho et al. Nature Reviews Neurology
- Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion
- (2010) S. Eftekhari et al. NEUROSCIENCE
- Origin of pain in migraine: evidence for peripheral sensitisation
- (2009) Jes Olesen et al. LANCET NEUROLOGY
- Do the unintended actions of botulinum toxin at distant sites have clinical implications?
- (2009) A. Curra et al. NEUROLOGY
- Neurobiology of migraine
- (2009) P.J. Goadsby et al. NEUROSCIENCE
- CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat
- (2008) J Zeller et al. BRITISH JOURNAL OF PHARMACOLOGY
- Modulation of Meningeal Nociceptors Mechanosensitivity by Peripheral Proteinase-Activated Receptor-2: The Role of Mast Cells
- (2008) X-C Zhang et al. CEPHALALGIA
- VPAC and PAC receptors: From ligands to function
- (2008) Louise Dickson et al. PHARMACOLOGY & THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now